Trial Profile
Clinical Outcome of Abatacept Therapy in Single Biologic Failure and Multiple Biologic Failure with Rheumatoid Arthritis Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 27 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.